BTK and Thrombocytopenia: In addition, patients demonstrating grade 3 thrombocytopenia with bleeding or grade 4 thrombocytopenia should not receive BTK inhibitor treatment until resolution to baseline or grade 1, following which, BTKi treatment can be restarted at a reduced dose.